register free | resend password

Medical Devices

Themenbereich / / Medical Devices


Sortiere PresseMitteilungen nach: Titel (A\D) Datum (A\D)

Seiten sind aktuell sortiert nach: Datum (erst neue PresseMitteilungen)

Global Ablation Devices Market 2023 : Focus on Industry, Growth, Size, Share, Dynamic Research Analysis, Trend, Forecast - Credence Research

According to the latest report published by Credence Research, Inc.& Hydrothermal Ablation; Device Types & Applications) : Growth, Future Prospects & Competition Assessment, 2016-2023, Browse the full Market Insights Ablation is a minimally invasive therapeutic procedure used for destruction and dissection ofdiseased tissue. Ablation is commonly used for treatment of conditions such as cancer, ophthalmic disorders urologic diseases, gynecological conditions and orthopedic disorders. Based on device type, this report categorizes ablation devices market into generators, catheters ...

12.12.2017

Spectral Announces Third Quarter Results

TORONTO, ONTARIO -- (Marketwired) -- 11/14/17 -- Spectral Medical Inc., (TSX: EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock, today announced its unaudited financial results for the third quarter ended September 30, 2017.Financial ReviewRevenue for the three months ended September 30, 2017 was $857,000 compared to $807,000 for the same period in the preceding year. For the nine months ended September 30, 2017 revenues were $2,888,000 compared to $2,739,000 in the same period of 2016. Revenues for both the quarter and the year were consiste ...

14.11.2017

Invuity Reports 2017 Third Quarter Financial Results

SAN FRANCISCO, CA -- (Marketwired) -- 11/07/17 -- (NASDAQ: IVTY), a leading medical technology company focused on minimal access surgery, today reported financial results for the quarter ended September 30, 2017.Revenue grew 13% to $9.6 million compared to revenue of $8.5 million in the third quarter of 2016.Disposable revenue grew 17% to $7.5 million compared to $6.4 million in the third quarter of 2016.Approximately 845 hospitals purchased Invuity devices in the third quarter of 2017, up from approximately 700 hospitals in the third quarter of 2016.PhotonBlade full launch was completed in ...

07.11.2017

Relevium Drives Top Line Growth for Q1

MONTREAL, QUEBEC -- (Marketwired) -- 11/06/17 -- (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce top line growth for Q1 in anticipation of its interim filings.What''s New Here?What Does This Mean?In M&A, the first six months of integration tends to be the most critical period, as such:Why Should Investors Care?First Quar ...

06.11.2017

Pressure BioSciences Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion into China

SOUTH EASTON, MA -- (Marketwired) -- 11/01/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, today announced that Professor Tiannan Guo''s laboratory at Westlake Institute for Advanced Study ("WIAS") has been named the Company''s first Center of Excellence ("CoE") in China. Professor Guo, M.D., Ph.D. and internationally-recognized proteomics expert P ...

01.11.2017

Spectral Provides Update on FDA Meeting Regarding Its PMA Submission for Toraymyxin(TM)

TORONTO, ONTARIO -- (Marketwired) -- 10/31/17 -- Spectral Medical Inc., (TSX: EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock, today announced the results of its recent meeting with the United States Food and Drug Administration ("FDA") concerning the status of its PMA application for Toraymyxin™.The meeting consisted of a general discussion of issues identified by the FDA after the first 100 days of regulatory review and suggestions for clarification of those issues. The Company committed to a timely response to the FDA' ...

31.10.2017

Relevium Files and Provides Comments on the Audited Consolidated Financial Statements for the Fiscal Year Ended June 30, 2017 and 2016

MONTREAL, QUEBEC -- (Marketwired) -- 10/31/17 -- (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce the filing of the company''s Audited Financial Statements and MD&A for the fiscal year ended June 30, 2017 and 2016 onNews Release HighlightsAn active fiscal year focused on acquisitionsThe fiscal year ended June 30, 2017 was ...

31.10.2017

Knee Tracker™ wins place at UK''s leading innovation show

Knee Tracker Ltd, a company from Lancashire has won a place in an exhibition of the most game-changing innovations from businesses across the country at the UK’s leading innovation show in November. Knee Tracker™ was one of 100 companies nationwide to be selected to exhibit its innovation to over 2,500 businesses at Innovate 2017 on November 8th and 9th at the NEC, Birmingham. Knee Tracker Ltd is a medical technology company specialising in mobile applications that motivate patients to do physiotherapy exercises and provide automatic feedback to them and their physiotherapist. Mr Sampath, Or ...

30.10.2017

Relevium Provides Operational Progress Update and Appoints Senior Marketing Officer

MONTREAL, QUEBEC -- (Marketwired) -- 10/27/17 -- (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce a brief operational update on progress and the appointment of a Senior Marketing Officer.News Release HighlightsAppointment of Senior Marketing Officeris pleased to announce it has appointed Abis Hussain as the company''s Senior ...

27.10.2017

H-Source Expands Team With Seasoned Supply Management Leader

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/26/17 -- H-Source Holdings Ltd. (TSX VENTURE: HSI)(OTCQB: HSCHF) (the "Company" or "H-Source") announces that supply chain leader Victor Garcia has joined the sales and consulting team as the Director of Account Management. Mr. Garcia comes to H-Source from Baylor University Medical Center in Dallas, Texas where for the past four years he has been the perioperative hospital supply chain manager. Mr. Garcia has extensive knowledge of hospital supply chain management, including the oversight of over $8 million of inventory ...

26.10.2017

Relevium Signs LOI to Acquire Nutraceutical Brand

MONTREAL, QUEBEC -- (Marketwired) -- 10/25/17 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on the acquisition and building of e-retail brands, products and technologies in the health and wellness market, is pleased to announce that it has signed a non-binding Letter Of Intent (the "LOI") to acquire an American based nutraceutical brand that sells products direct to consumers primarily through the channel in the category. The transaction value is currently esti ...

25.10.2017

Relevium Changes Auditors and Corporate Update

MONTREAL, QUEBEC -- (Marketwired) -- 10/20/17 -- Relevium Technologies Inc. (TSX VENTURE: RLV) and (FRANKFURT: 6BX) (the "Company" or "Relevium") announced today that it has changed auditors and appointed Ernst & Young LLP, Chartered Professional Accountants, as the Company''s new auditor (the "Successor Auditor"), replacing Nexia Freedman LLP, Chartered Professional Accountants (the "Former Auditor"). At the request of the Company, the Former Auditor has resigned and the Successor Auditor has been appointed as of the effective date of Oct ...

20.10.2017

Pressure BioSciences and Phasex Announce Strategic Collaboration Addressing Broad Markets for Stable, Water-Soluble Nanoemulsions

SOUTH EASTON, MA -- (Marketwired) -- 10/18/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry, today announced a collaboration with Phasex Corporation, one the world''s most experienced supercritical fluid ("SCF")-based toll processors. Since 1981, Phasex has been a leader in the development of cutting-edge, industrially-viable SCF-based separation processes for extracting, purifying, recrystalliz ...

18.10.2017

Spectral Announces Retirement of Chief Financial Officer

TORONTO, ONTARIO -- (Marketwired) -- 10/18/17 -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT) a Phase III Company advancing a precision treatment targeting specific patients at high risk of death from endotoxemic septic shock, today announced that Tony Businskas will be retiring as the Executive Vice President and CFO of the Company on January 31, 2018, after 12 years of service to the Company.Tony joined Spectral in 2005 from his role as a senior VP and CFO for MDS Pharma Services and quickly became an important and key member of the senior management t ...

18.10.2017

Spectral Presents Key EUPHRATES Trial Data at the Canadian Critical Care Forum

TORONTO, ONTARIO -- (Marketwired) -- 10/04/17 -- Spectral Medical Inc., (TSX: EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock, announced that, in a special plenary session this afternoon being held at the 2017 Canadian Critical Care Forum in Toronto, Dr. Paul Walker, President & CEO of Spectral, will deliver a presentation titled "Treatments for Septic Shock : New Insights from the EUPHRATES Trial." The presentation will be available afterwards on the Company''s website at .About SpectralSpectral is a Phase III compa ...

04.10.2017

Relevium Creates Alliance With Salavenia Nutrition and Biodevas Laboratoires to Develop an Exclusive Line of Phyto and Nutraceuticals for Pets

MONTREAL, QUEBEC -- (Marketwired) -- 09/28/17 -- (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to announce the launch of a joint cooperation with Salvenia Nutrition and to develop an exclusive brand and product line of nutraceuticals and phytoceuticals targeted to Pet Care owners on a direct to consumer basis. Product and market development initiatives are expected to begin in October of this year with the objective of a preliminary launch by Spring of 2018 as a wholly-owned subsidiary of .has retained Salvenia Nutrition ("Salvenia" ...

28.09.2017

Spectral Provides Regulatory Update on Its PMA Submission for Toraymyxin(TM)

TORONTO, ONTARIO -- (Marketwired) -- 09/21/17 -- Spectral Medical Inc., (TSX: EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock, today announced that, pursuant to the acceptance by the United States Food and Drug Administration ("FDA") of its PMA submission for Toraymyxin™ for filing on July 20, 2017, it has been engaged in an ongoing interactive review process with the FDA. Based on the filing acceptance date of July 20, 2017, the Company expects to receive more detailed feedback from the FDA on its PMA submission in the fourth qua ...

21.09.2017

Savaria Appoints New Director

LAVAL, QUEBEC -- (Marketwired) -- 09/20/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America''s leaders in the accessibility industry, is pleased to announce the appointment of Caroline Berube to the Board of Directors of the Corporation, effective immediately. The appointment expands the Board to eight directors, five of whom are independent.Caroline Berube, a Quebec-trained lawyer, admitted to practice in New York and Singapore, is the Managing Partner of HJM Asia Law, based in Singapore and China. She brings over 20 years ...

20.09.2017

Ventripoint Provides Corporate Update

TORONTO, ONTARIO -- (Marketwired) -- 09/20/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSX VENTURE: VPT) is pleased to provide a corporate update on its marketing and development plans.The Company has reviewed its sales approach and has met with a number of existing and potential customers to determine the highest value propositions in defined cardiac care settings. The Company has identified three settings where the VMS is regarded as critical to providing the best cardiac diagnosis and monitoring. This process has been completed and a direct sal ...

20.09.2017

Savaria Increases its Dividend by 38% and Declares its First Monthly Dividend

LAVAL, QUEBEC -- (Marketwired) -- 09/11/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Company"), one of North America''s leaders in the accessibility industry, announced today that its Board of Directors approved a 10 cent increase of the Company''s dividend, raising it from 26 cents ($0.26) to 36 cents ($0.36) per common share per year, representing an increase of 38%; the dividends, formerly paid quarterly, will now be paid monthly. The Board of Directors also declared the first monthly dividend of 3 cents ($0.03) per common share payable on ...

11.09.2017


Page 1 from 99:  1 2  3  4  5  .. » 99





All members: 8 030
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 60


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.